In re Accutane Litig., 2017 WL _____ (App. Div. July 25, 2017).  [Disclosure:  I argued for the successful plaintiffs in one of these two consolidated appeals, the one that involved the NJPLA.]  The New Jersey Product Liability Act, N.J.S.A. 2A:58C-4 (“NJPLA”), creates a presumption, which the Supreme Court has labeled a “virtually dispositive” “super-presumption,” that a manufacturer’s warning regarding a drug is adequate if that warning has been approved by the federal Food and Drug Administration.  The Supreme Court and the Appellate

Grande v. Saint Clare’s Health System, ___ N.J. ___ (2017).  Today’s unanimous, scholarly opinion by Justice Solomon, with an equally scholarly concurring opinion by Jsutice LaVecchia, arose from an appeal as of right in this Law Against Discrimination (“LAD”) case.  The Appellate Division split 2-1 as to whether there were genuine issues of material fact for trial, with the majority concluding that there were such issues.  The defendant, Saint C

Ocwen Loan Services, LLC v. Quinn, ___ N.J. Super. ___ (App. Div. 2017).  The doctrine of equitable subrogation provides that “a refinancing lender whose security turns out to be defective is subrogated by equitable assignment to the position of the lender whose lien discharged by the proceeds of [a] later loan, there being no prejudice to or justified reliance by a party in adverse interest.”  In today’s decision by Judge Carroll, the Appellate Division face